Medtronic Inc. (MDT)

MDT (NYSE:Health Services)
$49.84
pos +0.20
+0.40%
Today's Range: 49.24 - 49.84 | MDT Avg Daily Volume: 4,223,200
Last Update: 05/17/13 - 4:01 PM EDT
Volume: 5,568,419
YTD Performance: 21.50%
Open: $49.61
Previous Close: $49.64
52 Week Range: $35.67 - $50.17
Oustanding Shares: 1,013,805,980
Market Cap: 50,325,328,847
6-Month Chart
TheStreet Ratings Grade for MDT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 8 10
Moderate Buy 0 0 0 0
Hold 11 11 11 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.22 2.22 2.16 2.09
Latest Dividend: 0.26
Latest Dividend Yield: 2.10%
Dividend Ex-Date: 04/03/13
Price Earnings Ratio: 15.13
Price Earnings Comparisons:
MDT Sector Avg. S&P 500
15.13 15.10 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.77% 34.45% 17.19%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.60 0.11 0.03
Net Income 0.00 0.00 0.00
EPS 12.60 0.77 0.21
Earnings for MDT:
EBITDA 5.77B
Revenue 16.18B
Average Earnings Estimates
Qtr (04/13) Qtr (07/13) FY (04/13) FY (04/14)
Average Estimate $1.03 $0.90 $3.69 $3.82
Number of Analysts 16 14 17 17
High Estimate $1.04 $0.92 $3.70 $3.94
Low Estimate $1.02 $0.87 $3.68 $3.72
Prior Year $0.99 $0.85 $3.46 $3.69
Growth Rate (Year over Year) 4.29% 5.63% 6.61% 3.67%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Retsialg: If you ever doubted rolling stocks - take a look at $MDT - http://t.co/cAr933v3jB
9 hours ago from HootSuite
myrollingstocks: If you ever doubted rolling stocks - take a look at $MDT - http://t.co/vqMKnDIMgo
9 hours ago from HootSuite
myrollingstocks: If you ever doubted rolling stocks - take a look at $MDT - http://t.co/ZcuWcWR73f
1 day ago from HootSuite
Retsialg: If you ever doubted rolling stocks - take a look at $MDT - http://t.co/ZyIiavaOuO
1 day ago from HootSuite
blehr11: Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds http://t.co/qcfpCOiQHZ $BAX $BDX $LIFE $MDT
2 days ago from Tweet Button
jvtettamanzy: RT @SeekingAlpha: Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds http://t.co/fNKjdAtVZ4 $BAX $BDX $LIFE $MDT
2 days ago from Twitter for BlackBerry®
SeekingAlpha: Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds http://t.co/fNKjdAtVZ4 $BAX $BDX $LIFE $MDT
2 days ago from Seeking Alpha
micenter: Medtronic $MDT Could Break Through $50.02 Resistance Level ( http://t.co/t8tvWRdsia )
2 days ago from Marketintelligencecenter.com
w_pat_tc: WO2013070490A1 Introduction And Anchoring Tool For An Implantable Medical Device Element $MDT #A61N #A61N1 http://t.co/xWjXuhJRYy
2 days ago from TwittlyDumb
Sumenn7063: RT @SeekingAlpha: Large Hedge Fund Levin Capital's Top Stock Picks http://t.co/fpClsIfHQ3 $C $ETN $MDT $MRK $PFE
2 days ago from Twitter for iPhone

bearishMedtronic downgraded at Credit Suisse

May 16, 2013 | 8:11 AM EDT

MDT was downgraded from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $53 price target. 

By

Doug Kass

 | Apr 29, 2013 | 3:50 PM EDT
How much to buy?
By

David Katz

 | Feb 26, 2013 | 2:45 PM EST

Two domestic exploration and production names that scream 'buy me' are Devon and Southwestern. 

bullishMedtronic estimates, target increased at BMO

Feb 20, 2013 | 7:56 AM EST

MDT estimates were raised through 2015, BMO Capital said. Company continues to grow across the board. Outperform rating and new $52 price target. 

bearishMedtronic downgraded at Lazard

Feb 14, 2013 | 7:27 AM EST

MDT was downgraded to Neutral, Lazard Capital Markets said. Stock is up 30% over the past 8 months and the company lacks near-term catalysts. 

bearishMedtronic downgraded at Wunderlich

Jan 25, 2013 | 6:51 AM EST

MDT was downgraded from Buy to Hold, Wunderlich said. Valuation call, as the stock is up 13% year-to-date.

 

bullishMedtronic upgraded at Credit Suisse

Jan 17, 2013 | 8:22 AM EST

MDT was upgraded from Neutral to Outperform Credit Suisse said. $50 price target. Company can grow faster than consensus expectations over the coming quarters. 

updateJP Morgan Healthcare Conf.

Jan 7, 2013 | 7:11 AM EST

JPMorgan Global Healthcare Conference (Day 2 of 5) - 01/06/13 - 01/10/13 San Francisco, CA

bullishMedtronic upgraded at Mizuho

Jan 3, 2013 | 7:06 AM EST

MDT was upgraded from Neutral to Buy, Mizuho said. $49 price target. Spine business should grow through new products and insurance expansion.

 

By

David Peltier

 | Dec 5, 2012 | 5:30 AM EST

Portfolio Mgr. David Peltier analyzes a low-dollar stock on the verge of a potential turnaround.

A Special Thank You to Barron's

By

Brian Sozzi

 | May 18, 2013 | 6:48 AM EDT
I greatly appreciate the team for sharing my remembrance to Alan Abelson. It really did come from the heart. I am becom...

How to Obliterate an Earnings Call

By

Brian Sozzi

 | May 18, 2013 | 6:33 AM EDT
I approach an earnings call as I do eating a lobster: tear it apart and leave nothing for the dogs in the back alley. ...

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.